18600-60-7

Usage

Derivative of benzoic acid

2-(2-fluorobenzamido)benzoic acid is derived from benzoic acid, which means it has a similar structure with modifications.

Fluorine atom attached

The presence of a fluorine atom in the compound affects its chemical properties, such as reactivity and stability, and may influence its biological activity.

Amide group connection

An amide group (-CONH2) is connected to another benzene ring, which contributes to the compound's structure and properties.

Potential pharmaceutical applications

2-(2-fluorobenzamido)benzoic acid has potential uses in the development of new drugs, making it a valuable compound for pharmaceutical research.

Building block in organic synthesis

The compound can be used as a starting material or intermediate in the synthesis of other organic compounds, expanding its utility in chemical research and production.

Biological activity

2-(2-fluorobenzamido)benzoic acid has been studied for its potential biological activity, particularly in relation to its anti-inflammatory and analgesic properties, which could lead to the development of new therapeutic agents.

Upstream product

• 118-92-3 anthranilic acid 
• 393-52-2 2-Fluorobenzoyl chloride 
• 134-20-3 2-carbomethoxyaniline 
• 445-29-4 o-fluoro-benzoic acid 
• 18595-84-1 2-(2-fluorophenyl)-4H-benzo[d][1,3]oxazin-4-one 

Relevant academic research and scientific papers

2-(2-fluorobenzoylamino)benzoic acid

The structure of the title compound, C14H10FNO3, was determined at 173 K. The conformation of the molecule is such that both the F atom and the carbonyl O atom of the carboxyl group are located near the amide H atom. Molecules are linked to each other by centrosymmetric hydrogen-bonding interactions through the carboxyl groups, but there are no intermolecular hydrogen bonds involving the amide linkage.

Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells

Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes were designed as potential HSP90 inhibitors. A series of the compounds was synthesized by oximation of (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-ones followed by O-acylation with acylamid

Precursor-directed combinatorial biosynthesis of cinnamoyl, dihydrocinnamoyl, and benzoyl anthranilates in saccharomyces cerevisiae

Biological synthesis of pharmaceuticals and biochemicals offers an environmentally friendly alternative to conventional chemical synthesis. These alternative methods require the design of metabolic pathways and the identification of enzymes exhibiting ade